mMRC Dyspnoea Scale
iatroX editorial team · Updated · Record checked · editorial policy
The modified Medical Research Council dyspnoea scale grades functional breathlessness on a 0–4 scale. It is used alongside exacerbation history in the GOLD COPD assessment framework to guide treatment escalation.
inputs
evidence
derivation
The MRC breathlessness scale was originally published by Fletcher et al. (1959) and subsequently modified (mMRC) for simplified clinical use. It is one of the oldest standardised dyspnoea assessment tools.
validation
The mMRC correlates with lung function (FEV1), exercise capacity (6MWT), quality of life, and mortality in COPD. It is endorsed by GOLD as an alternative to CAT for symptom assessment in COPD classification.
guideline endorsements
GOLD 2025 Report: mMRC ≥2 (or CAT ≥10) defines 'more symptoms' for COPD group classification. NICE NG115 (COPD): references mMRC for symptom assessment. BTS/SIGN COPD guidelines reference mMRC.
references
- Fletcher CM, Elmes PC, Fairbairn AS, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. BMJ. 1959;2(5147):257-266.PMID: 13823475
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD. 2025 Report.link ↗
- NICE Guideline NG115. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2018 (updated 2019).link ↗